Axon Enterprise Inc. (AXON) is a leading technology provider in global public safety, serving law enforcement, military, and civilians. With a market cap of $60.5 billion, the company operates through two segments, Software and Sensors, and TASER. As a large-cap stock, Axon Enterprise is known for its TASER energy weapons, body-worn cameras, digital evidence management systems, and AI-powered software available on its cloud-based Axon Cloud platform.
AXON stock has experienced some fluctuations, with a 3.6% decline from its 52-week high of $806.64. However, over the past three months, the stock has surged by 40.1%, outperforming the broader Nasdaq Composite, which saw a 9.6% increase during the same period. In the long term, AXON stock has shown impressive growth, up 30.8% year-to-date and 161.7% over the past 52 weeks, compared to NASX’s 1.1% and 9.3% gains, respectively.
Despite some fluctuations, AXON stock has consistently traded above its 50-day and 200-day moving averages since last year. The company’s strong performance was evident in its Q1 2025 results, where it posted record quarterly revenue of $603.6 million, up 31.3% year-over-year. This performance was driven by growth in Software & Services, robust adoption of TASER 10 and Axon Body 4, and increasing demand for platform sensors. Adjusted EPS came in at $1.41, a 22.6% increase from the previous year and above consensus estimates.
Encouraged by its momentum, Axon Enterprise raised its full-year 2025 revenue guidance to a range of $2.6 billion to $2.7 billion, up from its previous projection. In comparison to its rival L3Harris Technologies, Inc. (LHX), AXON stock has outperformed, with LHX stock lagging behind with a 13.7% increase over the past 52 weeks.
Analysts are optimistic about Axon Enterprise’s prospects, with a consensus rating of “Strong Buy” among the 15 analysts covering the stock. The stock is currently trading above the mean price target of $735. It’s important to note that the information provided in this article is solely for informational purposes and does not reflect any personal investments in the securities mentioned. For more details, you can visit the original article on Barchart.com.
